These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30047671)
1. Cancer heterogeneity, patient diversity and next-generation cognitive computing. Makhoul I J Ark Med Soc; 2016 Dec; 113(6):126. PubMed ID: 30047671 [No Abstract] [Full Text] [Related]
2. Increasing access to next-generation sequencing in oncology for Brazil. Santos M; Coudry RA; Ferreira CG; Stefani S; Cunha IW; Zalis MG; Araujo LH Lancet Oncol; 2019 Jan; 20(1):20-23. PubMed ID: 30614460 [No Abstract] [Full Text] [Related]
3. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality. MacConaill LE; Lindeman NI; Rollins BJ JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886 [No Abstract] [Full Text] [Related]
4. Personalized medicine in oncology: next generation. Chiang A; Million RP Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983 [No Abstract] [Full Text] [Related]
5. Oncologists partner with Watson on genomics. Cancer Discov; 2015 Aug; 5(8):788. PubMed ID: 26080837 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics in cancer therapeutics--hype or hope? Simon R Nat Clin Pract Oncol; 2005 May; 2(5):223. PubMed ID: 16264939 [No Abstract] [Full Text] [Related]
7. Next-generation sequencing in precision oncology: challenges and opportunities. Kruglyak KM; Lin E; Ong FS Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810 [TBL] [Abstract][Full Text] [Related]
8. Bringing Precision Medicine to Community Oncologists. Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232 [TBL] [Abstract][Full Text] [Related]
9. Integrated patient and tumor genetic testing for individualized cancer therapy. Hertz DL; McLeod HL Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014 [TBL] [Abstract][Full Text] [Related]
11. Cancer genome explosion and systems biology: impact on surgical oncology? Roukos DH Ann Surg Oncol; 2011 Jan; 18(1):12-5. PubMed ID: 20890728 [No Abstract] [Full Text] [Related]
12. Precision oncology: where next? Gore M; Larkin J Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189 [No Abstract] [Full Text] [Related]
13. [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin; 2013 Mar; 65(1):52-3. PubMed ID: 23593823 [No Abstract] [Full Text] [Related]
14. Fantastic voyage: the future of cancer diagnostics. Sundaresan TK; Haber DA Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190 [No Abstract] [Full Text] [Related]
15. Impact of Cancer Biotechnology on Diagnostic and Prognostic Indicators in Predictive Oncology and Therapy. Nice, France, October 26-28, 1996. Abstracts. Cancer Detect Prev; 1996; 20(5):391-555. PubMed ID: 8951217 [No Abstract] [Full Text] [Related]
16. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer. Sharma AK Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038 [No Abstract] [Full Text] [Related]
17. Recent developments in cancer therapy and why we need a human cancer genome project. Becker GJ J Am Coll Radiol; 2005 Nov; 2(11):887-8. PubMed ID: 17411961 [No Abstract] [Full Text] [Related]
18. A Multifaceted Battle Against Cancer. Liu X; Reiss C Yale J Biol Med; 2015 Jun; 88(2):105-6. PubMed ID: 26219136 [No Abstract] [Full Text] [Related]
19. Fruits of molecular studies include gene linking diet and cancer, novel markers for malignancy. Stephenson J JAMA; 1995 Aug; 274(5):369-70. PubMed ID: 7616620 [No Abstract] [Full Text] [Related]
20. Systems medicine: a real approach for future personalized oncology? Roukos DH Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782 [No Abstract] [Full Text] [Related] [Next] [New Search]